Search Results - "Qian, Yunsong"
-
1
CHI3L1 in the pathophysiology and diagnosis of liver diseases
Published in Biomedicine & pharmacotherapy (01-11-2020)“…Associated signal pathways of CHI3L1. [Display omitted] Chitinase 3-like protein 1(CHI3L1) participates in physiological and pathophysiological process, such…”
Get full text
Journal Article -
2
Exploring the efficacy and safety of polyene phosphatidylcholine for treatment of drug-induced liver injury using the Roussel Uclaf causality assessment method: a propensity score matching comparison
Published in Journal of international medical research (01-08-2021)“…Objective In China, polyene phosphatidylcholine (PPC) is widely used to treat alanine aminotransferase (ALT) elevation associated with various liver diseases…”
Get full text
Journal Article -
3
Tenofovir is superior to entecavir in reducing HCC for patients with HBV-related compensated cirrhosis at high HCC risk scores
Published in Therapeutic advances in chronic disease (2022)“…Background: Both tenofovir disoproxil fumarate (TDF) and entecavir (ETV) are known to reduce the risk of hepatocellular carcinoma (HCC) in patients with…”
Get full text
Journal Article -
4
MCF2L-AS1 promotes the biological behaviors of hepatocellular carcinoma cells by regulating the miR-33a-5p/FGF2 axis
Published in Aging (Albany, NY.) (10-07-2023)“…Long noncoding RNA MCF2L-AS1 functions in the development of cancers like lung cancer, ovarian cancer, and colorectal cancer. Notwithstanding, its function in…”
Get full text
Journal Article -
5
Novel, high accuracy models for hepatocellular carcinoma prediction based on longitudinal data and cell-free DNA signatures
Published in Journal of hepatology (01-10-2023)“…Current hepatocellular carcinoma (HCC) risk scores do not reflect changes in HCC risk resulting from liver disease progression/regression over time. We aimed…”
Get full text
Journal Article -
6
Early detection of hepatocellular carcinoma using cfDNA signatures from cirrhotic patients with nodules
Published in Journal of clinical oncology (01-06-2022)“…4113 Background: Hepatocellular carcinoma (HCC) is the fourth most common cause of cancer-related death worldwide. Early detection of HCC patients is related…”
Get full text
Journal Article -
7
Validation of the hepatocellular carcinoma early detection screening algorithm Doylestown and aMAP in a cohort of Chinese with cirrhosis
Published in Journal of clinical laboratory analysis (01-04-2022)“…Background Previous studies have developed some blood‐based biomarker algorithms such as the Doylestown algorithm and aMAP score to improve the detection of…”
Get full text
Journal Article -
8
Novel, high accuracy prediction models of hepatocellular carcinoma based on longitudinal data and cell-free DNA signatures
Published in Journal of hepatology (01-06-2023)Get full text
Journal Article -
9
OS-033 - Novel, high accuracy prediction models of hepatocellular carcinoma based on longitudinal data and cell-free DNA signatures
Published in Journal of hepatology (01-06-2023)Get full text
Journal Article -
10
The clinical significance of serum chitinase 3‐like 1 in hepatitis B–related chronic liver diseases
Published in Journal of clinical laboratory analysis (01-05-2020)“…Aim In the present study, we purposed to determine serum chitinase 3‐like 1 (CHI3L1) expression characteristics in chronic liver diseases monoinfected with…”
Get full text
Journal Article -
11
Early warning of hepatocellular carcinoma in cirrhotic patients by three-phase CT-based deep learning radiomics model: a retrospective, multicentre, cohort studyResearch in context
Published in EClinicalMedicine (01-08-2024)“…Background: The diagnosis of hepatocellular carcinoma (HCC) often experiences latency, ultimately leading to unfavorable patient outcomes due to delayed…”
Get full text
Journal Article -
12
Early warning of hepatocellular carcinoma in cirrhotic patients by three-phase CT-based deep learning radiomics model: a retrospective, multicentre, cohort study
Published in EClinicalMedicine (01-08-2024)“…The diagnosis of hepatocellular carcinoma (HCC) often experiences latency, ultimately leading to unfavorable patient outcomes due to delayed therapeutic…”
Get full text
Journal Article